<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02112695</url>
  </required_header>
  <id_info>
    <org_study_id>1208051</org_study_id>
    <secondary_id>2013-004733-32</secondary_id>
    <nct_id>NCT02112695</nct_id>
  </id_info>
  <brief_title>Opioid System Cerebral Activity in Endurance Sportswomen - Addiction or Denutrition ? [11C]Diprenorphine PET Study</brief_title>
  <official_title>Opioid System Cerebral Activity in Endurance Sportswomen - Addiction or Denutrition ? [11C]Diprenorphine PET Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Universitaire de Saint Etienne</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Ministry of Health, France</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Centre Hospitalier Universitaire de Saint Etienne</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Abnormal opioid system have been identified in addictive behavior and activity of the opioid
      system has also shown a strong link with the nutritional balance. A significant increase in
      endorphin levels was noticed after exercise, proportional to the duration and intensity of
      this activity. One brain imaging study showed an increase in opioid activity in athletes
      after endurance training. However , a decrease in opioid tone related to receptor
      desensitization in the brain has been raised in the sport and it is possible to feel like ,
      the subject must perform physical exercise more frequently . Consequently, in order to deepen
      the hypothesis of addiction in high-level sport , the brain opioid activity should be
      assessed pre- training compared to a group of sedentary control subjects .

      Preliminary results of a previous study the investigators are conducting on anorexia nervosa
      (AN ) show abnormalities that appear to be involved in self addiction anorexia nervosa and
      the regulation of gonadal function. However, the relation of cause and effect between these
      anomalies and undernutrition remains to be determined . Given the addictive component in the
      endurance sport and the variability of the nutritional status of its practitioners ,
      evaluation of brain activity in these subjects could provide additional answers.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 15, 2014</start_date>
  <completion_date type="Anticipated">March 2018</completion_date>
  <primary_completion_date type="Anticipated">March 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>[11C]diprenorphine binding potential</measure>
    <time_frame>2 weeks</time_frame>
    <description>Value of [11C]diprenorphin binding potential in predifined brains regions. [11C]diprenorphin BP will be evaluated by brain positron emission tomography and MRI exam</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>correlation [11C]diprenorphine BP</measure>
    <time_frame>2 weeks</time_frame>
    <description>Correlation between [11C]Diprenorphine binding potential and plasma endogenous opioid levels</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>correlation [11C]diprenorphine BP</measure>
    <time_frame>2 weeks</time_frame>
    <description>Correlation between [11C]Diprenorphine binding potential and psychometric score evaluating addictive behavior, reward and positive reinforcement</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>correlation [11C]diprenorphine BP</measure>
    <time_frame>2 weeks</time_frame>
    <description>Correlation between [11C]Diprenorphine binding potential and appetite regulating hormones</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>correlation [11C]diprenorphine BP</measure>
    <time_frame>2 weeks</time_frame>
    <description>Correlation between [11C]Diprenorphine binding potential and LH response during GnRH test</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">45</enrollment>
  <condition>Sports Nutritional Sciences</condition>
  <arm_group>
    <arm_group_label>sportswomen</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>3 micrograms [11C]diprenorphine</description>
  </arm_group>
  <arm_group>
    <arm_group_label>control subjects</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>3 micrgrams [11C]diprenorphine</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>[11C]diprenorphine</intervention_name>
    <description>3 micrograms [11C]diprenorphine - intravenous use - 1 time</description>
    <arm_group_label>sportswomen</arm_group_label>
    <arm_group_label>control subjects</arm_group_label>
    <other_name>radiopharmacentical precursor solution</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        For High-level sportswomen :

          -  18-35-year-old

          -  High-level sportswomen

          -  BMI&gt;19kg/m2

          -  Absence of eating disorders

          -  In pre-competition period

          -  Signature of written consent

        For controls :

          -  18-35-year-old

          -  Sedentary normal weight women

          -  BMI&gt;19kg/m2

          -  Normal nutritional markers

          -  Absence of eating disorders or other psychiatric or organic diseases

        Exclusion Criteria:

          -  Oral contraception

          -  Heart failure

          -  Neuroleptics, antiparkinson drugs, alpha-methyl-dopa, beta blockers, inhibitors of
             monoamine oxidase-A or MOA-B, tricyclic antidepressants, selective serotonin reuptake
             inhibitor, thyme-regulators (lithium), anticonvulsant drugs, codeine, morphine, drugs
             containing tramadol, dopaminergic drugs
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>35 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Bruno Estour, PU-PH</last_name>
    <role>Principal Investigator</role>
    <affiliation>CHU Saint-Etienne</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Bruno ESTOUR, PU PH</last_name>
    <phone>(0)477127727</phone>
    <phone_ext>+33</phone_ext>
    <email>bruno.estour@chu-st-etienne.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Florence Rancon</last_name>
    <phone>(0)47712084</phone>
    <email>florence.rancon@chu-st-etienne.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Service d'Endocrinologie - CHU Saint-Etienne</name>
      <address>
        <city>Saint-Etienne</city>
        <zip>42055</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Bruno Estour, PU PH</last_name>
      <phone>(0)477127727</phone>
      <phone_ext>+33</phone_ext>
      <email>bruno.estour@chu-st-etienne.fr</email>
    </contact>
    <investigator>
      <last_name>Bogdan Galusca, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Roger Oullion, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>October 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 10, 2014</study_first_submitted>
  <study_first_submitted_qc>April 11, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 14, 2014</study_first_posted>
  <last_update_submitted>October 17, 2017</last_update_submitted>
  <last_update_submitted_qc>October 17, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">October 18, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>endurance sportswomen</keyword>
  <keyword>addiction</keyword>
  <keyword>undernutrition</keyword>
  <keyword>[11C]diprenorphine Pet</keyword>
  <keyword>pituitary region</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Behavior, Addictive</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diprenorphine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

